QQ客服 官方微博 反馈留言

	Effectiveness of crizotinib in a patient with mesenchymal-epithelial transition overexpression/fluorescence in situ hybridization-negative/next-generation sequencing-negative advanced lung adenocarcinoma: a case report
	Song, Peng; Liu, Li; Liu, Yutao; Zhang, Tao; Guo, Lei; Li, Weihua; Xing, Jianming; Yang, Lin; Gao, Shugeng
	2019
卷号	8期号:2页码:705-708
关键词	Lung adenocarcinoma crizotinib immunohistochemistry (IHC) fluorescence in situ hybridization (FISH) next-generation sequencing (NGS)
ISSN号	2218-676X
DOI	10.21037/tcr.2019.03.14
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6341324
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Song, Peng,Liu, Li,Liu, Yutao,et al. Effectiveness of crizotinib in a patient with mesenchymal-epithelial transition overexpression/fluorescence in situ hybridization-negative/next-generation sequencing-negative advanced lung adenocarcinoma: a case report[J],2019,8(2):705-708.
APA	Song, Peng.,Liu, Li.,Liu, Yutao.,Zhang, Tao.,Guo, Lei.,...&Gao, Shugeng.(2019).Effectiveness of crizotinib in a patient with mesenchymal-epithelial transition overexpression/fluorescence in situ hybridization-negative/next-generation sequencing-negative advanced lung adenocarcinoma: a case report.,8(2),705-708.
MLA	Song, Peng,et al."Effectiveness of crizotinib in a patient with mesenchymal-epithelial transition overexpression/fluorescence in situ hybridization-negative/next-generation sequencing-negative advanced lung adenocarcinoma: a case report".8.2(2019):705-708.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。